Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life.

ABSTRACT:

Objectives

Oral treatment (targeted or chemotherapy) for cancer is being increasingly used. While fatigue is a known side effect of intravenous chemotherapy, the rate of fatigue and the impact of fatigue on other patient-reported outcomes are not well described.

Method

At Massachusetts General Hospital Cancer Center, 180 adult patients prescribed oral targeted or chemotherapy for various malignancies enrolled in a randomized controlled trial of adherence and symptom management. Patients completed baseline self-reported measures of fatigue (Brief Fatigue Inventory; BFI), anxiety and depressive symptoms (Hospital Anxiety and Depression Scale; HADS), and quality of life, including subscales for physical, social, emotional, and functional well-being ([QOL] Functional Assessment

SUBMITTER: Poort H 

PROVIDER: S-EPMC7489872 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature